Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leach, M. W.
Right arrow Articles by Cartwright, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leach, M. W.
Right arrow Articles by Cartwright, M. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Renal Changes Associated with Naproxen Sodium Administration in Cynomolgus Monkeys

Michael W. Leach

Schering-Plough Research Institute, Lafayette, New Jersey 07848, michael.leach{at}spcorp.com.

Doyle W. Frank

Schering-Plough Research Institute, Lafayette, New Jersey 07848

Mark R. Berardi

Schering-Plough Research Institute, Lafayette, New Jersey 07848

Ellen W. Evans

Schering-Plough Research Institute, Lafayette, New Jersey 07848

Robert C. Johnson

Schering-Plough Research Institute, Lafayette, New Jersey 07848

David G. Schuessler

Schering-Plough Research Institute, Lafayette, New Jersey 07848

Elaine Radwanski

Schering-Plough Research Institute, Kenilworth, New Jersey 07033

Mark E. Cartwright

Schering-Plough Research Institute, Lafayette, New Jersey 07848

Naproxen sodium was administered to cynomolgus monkeys (Macaca fascicularis) by oral gavage at daily doses of 44, 88, or 176 mg/kg for 2 wk (2 monkeys/gender) or of 44 mg/kg for 13 wk (4 monkeys/gender). Body weight loss occurred in at least one monkey in all naproxen sodium-dosed groups in the 2-wk (up to 16% loss) and 13-wk (up to 22% loss) studies. Increases in plasma naproxen concentrations were dose proportional between 44 and 88 mg/kg but were less than dose proportional between 88 and 176 mg/kg. Up to 2-fold increases in creatinine and/or serum urea nitrogen values as well as higher renal weights occurred in monkeys receiving 176 mg/kg for 2 wk or 44 mg/kg for 13 wk. Microscopically, renal changes were observed in all naproxen sodium-dosed groups. Renal findings after 2 wk of exposure included increased interstitial ground substance, tubular dilatation, and tubulointerstitial nephritis; in the 13-wk study, cortical tubular atrophy and interstitial fibrosis were also observed. These studies identify the kidney as the target organ of naproxen sodium in cynomolgus monkeys.

Key Words: Naproxen • nonsteroidal anti-inflammatory drugs • pharmacokinetics • kidney • nephritis • cynomolgus monkey • toxicity

References

  • Aabakken L., Dybdahl JH, Eisaunet W., Haaland A., Larsen S., and Osnes M. (1989). Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 24: 1007-1013.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Adams DH, Howie AJ, Michael J., McConkey B., Bacon PA, and Adu D. (1986). Non-steroidal anti-inflammatory drugs and renal failure. Lancet 1: 57-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bach PH, Grasso P., Molland EA, and Bridges JW (1983). Changes in medullary glycosaminoglycan histochemistry and microvascular filling during the development of 2-bromoethanamine hydrobromide-induced renal papillary necrosis. Toxicol. Appl. Pharmacol. 69: 333-344.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bach PH and Thanh Ntk (1998). Renal papillary necrosis—40 years on. Toxicol. Pathol. 26: 73-91.[Abstract/Free Full Text]
  • Bender WL, Whelton A., Beschorner WE, Darwish MO, Hall-Craggs M., and Solez K. (1984). Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate. Am. J. Med. 76: 1006-1012.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Black HE (1986). Renal toxicity of non-steroidal anti-inflammatory drugs. Toxicol. Pathol. 14: 83-90.[Abstract/Free Full Text]
  • Blackshear JL, Napier JS, Davidman M., and Stillman MT (1985). Renal complications of nonsteroidal antiinflammatory drugs: Identification and monitoring of those at risk. Semin. Arthritis Rheum. 14: 163-175.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Burry A. (1978). Pathology of analgesic nephropathy: Australian experience. Kidney Int. 13: 34-40.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Burry AF (1967). The evolution of analgesic nephropathy. Nephron 5: 185-201.[Web of Science]
  • Cheville NF (1994). Ultrastructural Pathology. An Introduction to Interpretation, 1st ed. Iowa State University Press, Ames.
  • Cinotti GA (1984). Clinical assessment of the renal toxicity of antirheumatic drugs. Arch. Toxicol. Suppl. 7: 338-349.[Medline] [Order article via Infotrieve]
  • Clausen E. and Jensen K. (1968). Renal biopsies from patients with a high analgesic intake. Acta Pathol. Microbiol. Scand. 72: 219-232.[Web of Science][Medline] [Order article via Infotrieve]
  • Clive DM and Stoff JS (1984). Renal syndromes associated with nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 310: 563-572.[Web of Science][Medline] [Order article via Infotrieve]
  • Cronin RE and Henrich WL (1996). Toxic nephropathy. In: Brenner & Rector's The Kidney, 5th ed., BM Brenner (ed). W. B. Saunders, Philadelphia, pp. 1680-1711.
  • Dahl H. (1986). Naproxen (Naprosyn®). Pharmacokinetics: Therapeutical relevance and tolerance profile. Cephalalgia Suppl. 4: 69-75.
  • Davies DJ (1968). Changes in the renal cortex following experimental medullary necrosis. Arch. Pathol. 86: 377-382.[Web of Science]
  • De Broe ME and Elseviers MM (1998). Analgesic nephropathy. N. Engl. J. Med. 338: 446-452.[Free Full Text]
  • DeArmond B, Francisco CA, Lin J-S., Huang F-Y., Halladay S., Bartizek RD, and Skare KL (1995). Safety profile of over-the-counter naproxen sodium. Clin. Ther. 17: 587-601.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Devane JG, Butler J., and Mulligan S. (1996). IPDAS: A novel technology brings new benefits when applied to naproxen sodium. Am. J. Orthop. 25: 7-13.[Medline] [Order article via Infotrieve]
  • Elliott GA, Purmalis A., VanderMeer DA, and Denlinger RH (1988). The propionic acids. Gastrointestinal toxicity in various species. Toxicol. Pathol. 16: 245-250.[Web of Science][Medline] [Order article via Infotrieve]
  • Emerson JL (1976). Chronic oral toxicity of a nonsteroidal antiinflammatory agent in rhesus monkeys. Toxicol. Appl. Pharmacol. 37: 184 (abstract).
  • Erslev AJ and Besarab A. (1997). Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int. 51: 622-630.[Web of Science][Medline] [Order article via Infotrieve]
  • Finkelstein A., Fraley DS, Stachura I., Feldman HA, Gandy DR, and Bourke E. (1982). Fenoprofen nephropathy: Lipoid nephrosis and interstitial nephritis. Am. J. Med. 72: 81-87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gault MH, Blennerhassett J., and Muehrcke RC (1971). Analgesic nephropathy: A clinicopathologic study using electron microscopy. Am. J. Med. 51: 740-756.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Giercksky K-E., Huseby G., and Rugstad H-E. (1989). Epidemiology of NSAID-related gastrointestinal side effects. Scand. J. Gastroenterol. Suppl. 163: 3-8.[Medline] [Order article via Infotrieve]
  • Gloor FJ (1978). Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. Kidney Int. 13: 27-33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gregg NJ, Elseviers MM, De Broe ME, and Bach PH (1989). Epidemiology and mechanistic basis of analgesic-associated nephropathy. Toxicol. Lett. 46: 141-151.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hallesy DW, Shott LD, and Hill R. (1973). Comparative toxicology of naproxen. Scand. J. Rheumatol. Suppl. 2: 20-28.[CrossRef]
  • Hallgren R., Gerdin B., and Tufveson G. (1990). Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J. Exp. Med. 171: 2063-2076.[Abstract/Free Full Text]
  • Insel PA (1996). Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: The Pharmacologic Basis of Therapeutics, 9th ed., JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, and AG Gilman (eds). McGraw-Hill, New York, pp. 617-657.
  • Kaissling B., Hegyi I., Loffing J., and Le Hir M. (1996). Morphology of interstitial cells in the healthy kidney. Anat. Embryol. 193: 303-318.[Medline] [Order article via Infotrieve]
  • Krantz SB (1994). Pathogenesis and treatment of the anemia of chronic disease. Am. J. Med. Sci. 307: 353-359.[Web of Science][Medline] [Order article via Infotrieve]
  • Lucke VM, Messervy M., Lucke JN, and Hunt AC (1968). Effects on the kidney of removal of the renal papilla. Arch. Pathol. 86: 390-394.[Web of Science]
  • Maniglia R., Schwartz AB, and Moriber-Katz S. (1988). Non-steroidal anti-inflammatory nephrotoxicity. Ann. Clin. Lab. Sci. 18: 240-252.[Abstract]
  • McAlindon ME, Cook GA, Elliott SL, Hawkey CJ, and Yeomans ND (1995). Gastric microbleeding following single and repeated dosing with naproxen. Aliment. Pharmacol. Ther. 9: 655-659.[Web of Science][Medline] [Order article via Infotrieve]
  • Medical Economics Company, Inc. (1998). Physician's Desk Reference, 52nd ed. Medical Economics Company, Inc., Montvale, New Jersey.
  • Molland EA (1978). Experimental renal papillary necrosis. Kidney Int. 13: 5-14.[Web of Science][Medline] [Order article via Infotrieve]
  • Moyer S. (1986). Pharmacokinetics of naproxen sodium. Cephalalgia 6: 77-80.[Web of Science][Medline] [Order article via Infotrieve]
  • Murray MD and Brater DC (1993). Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 32: 435-465.
  • Pitcock JA, Lyons H., Brown PS, Rightsel WA, and Muirhead EE (1988). Glycosaminoglycans of the rat renomedullary interstitium: Ultrastructural and biochemical observations. Exp. Mol. Pathol. 49: 373-387.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pitcock JA, Rightsel WA, Brown P., Brooks B., and Muirhead EE (1976). Functional-morphological correlates of renomedullary interstitial cells. Clin. Sci. Mol. Med. Suppl. 51: 291s-293s.
  • Reeves WB, Foley RJ, and Weinman EJ (1985). Nephrotoxicity from nonsteroidal anti-inflammatory drugs. South. Med. J. 78: 318-322.[Web of Science][Medline] [Order article via Infotrieve]
  • Roskiewicz A., Roskiewicz J., and Zawistowski S. (1982). The effect of indomethacin on the ultrastructure of renomedullary interstitial cells of the rat. Gegenbaurs Morphol. Jahrb. 128: 702-711.[Medline] [Order article via Infotrieve]
  • Runkel R., Chaplin M., Boost G., Serge E., and Forchielli E. (1972). Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J. Pharm. Sci. 61: 703-708.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Runkel R., Forchielli E., Sevelius H., Chaplin M., and Segre E. (1974). Nonlinear plasma level response to high doses of naproxen. Clin. Pharmacol. Ther. 15: 261-266.[Web of Science][Medline] [Order article via Infotrieve]
  • Serge EJ (1980). Naproxen sodium (Anaprox). Pharmacology, pharmacokinetics. and drug interactions. J. Reprod. Med. 25: 222-225.[Web of Science][Medline] [Order article via Infotrieve]
  • Serge EJ (1983). Naproxen. In: Anti-Rheumatic Drugs, EC Huskisson (ed). Praeger Publishers, New York, pp. 401-419.
  • Sevelius H., Runkel R., Serge E., and Bloomfield SS (1980). Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br. J. Clin. Pharmacol. 10: 259-263.[Web of Science][Medline] [Order article via Infotrieve]
  • Skelton-Stroud PN and Glaister JR (1987). Naturally occurring renal disease in non-human primates. In: Nephrotoxicity in the Experimental and Clinical Situation, PH Bach and EA Lock (eds). Martinus Nijhoff Publishers, Dordrecht, The Netherlands, pp. 189-210.
  • Stachura I., Jayakumar S., and Bourke E. (1983). T and B lymphocyte subsets in fenoprofen nephropathy. Am. J. Med. 75: 9-16.[Web of Science][Medline] [Order article via Infotrieve]
  • Thompson GF and Collins JM (1973). Urinary metabolic profiles for choosing test animals for chronic studies: Application to naproxen. J. Pharm. Sci. 62: 937-941.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Todd PA and Clissold SP (1990). Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs 40: 91-137.[Web of Science][Medline] [Order article via Infotrieve]
  • Wallis PJ, Lodwick R., Sinha SK, and Constable TJ (1989). Effect of naproxen on renal haemodynamics in elderly patients with arthritis. Age Ageing 18: 26-30.[Abstract/Free Full Text]
  • Whelton A., Watson AJ, and Rock RC (1996). Nitrogen metabolites and renal function. In: Tietz Fundamentals of Clinical Chemistry, 4th ed., CA Burtis and ER Ashwood (eds). W. B. Saunders Company, Philadelphia, pp. 569-591.

Toxicologic Pathology, Vol. 27, No. 3, 295-306 (1999)
DOI: 10.1177/019262339902700305
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Vet PatholHome page
R. E. Guzman, K. Datta, and N. K. Khan
Obstructive Protein Cast Nephropathy in Cynomolgus Monkeys Treated with Small Organic Molecules
Vet. Pathol., November 1, 2008; 45(6): 945 - 948.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leach, M. W.
Right arrow Articles by Cartwright, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leach, M. W.
Right arrow Articles by Cartwright, M. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?